fbpx

3,000 lives saved in first year of Take-Home Naloxone program

31 August 2023

 

This International Overdose Awareness Day, the Pharmaceutical Society of Australia (PSA) recognises the important role pharmacists play in supporting patients taking prescription opioids, noting that in its first year alone, the Take Home Naloxone (THN) program has saved 3000 lives.

 

The national THN program provides naloxone to anyone who may experience, or witness, an opioid overdose or adverse reaction for free and without a prescription.

 

Since the THN program began on 1 July 2022, an estimated 3,000 doses have been used by Australians experiencing or witnessing an opioid overdose or adverse reaction equating to 8 uses per day.

 

PSA National President Dr Fei Sim FPS says that pharmacists have been key to the success of the program because of their accessibility and expertise.

 

“The Take Home Naloxone program has saved Australian lives,” Dr Sim said.

 

“Evidence from the first year of the THN program shows that pharmacists are well-placed to provide naloxone, whether alongside a prescribed opioid or as a stand-alone supply.

 

“As our most accessible healthcare professionals, pharmacists have distributed over 90% of naloxone for the THN Program. This is evidence that pharmacist-provided naloxone as one of the harm minimisation initiatives, alongside counselling, is feasible and acceptable by Australians.

 

“To ensure ongoing sustainability and impact, pharmacists must be empowered and supported to provide this life-saving service.

 

“We are urging anyone taking opioids for pain management, or caring for someone who does, to have a conversation with your local pharmacist about having naloxone on-hand. We can also provide advice about identifying an opioid overdose and how to respond during an emergency.

 

“Over recent years we have seen more cases of illicit party drugs being spiked with acetyl-fentanyl which can cause opioid overdoses even in small amounts.

 

“Your pharmacist is there to provide judgement-free, expert advice on when and how to use this life-saving drug.

 

“It could save your life, or the life of a friend.”

 

Take Home Naloxone is available to Australians through their local pharmacist. PSA recommends calling ahead to ensure your local pharmacy participates in the THN program and has available stock.

 

Key facts:

  • Up to 8 lives saved each day from use of Take-Home Naloxone
  • Over 110,000 Australians are currently struggling with opioid dependence
  • 7% of unintentional drug-induced deaths in 2021 involved opioids

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

 

Data from 1 July 2022 to 30 June 2023, provided by the Department of Health and Aged Care.

Penington Institute Australia Annual Overdose Report 2023

Pharmacists can deliver on current and future challenges

25 August 2023

 

Following the release of the Australian Government’s Intergenerational Report 2023, the Pharmaceutical Society of Australia (PSA) has called for pharmacists to be able to do more to support the country’s increased healthcare needs as our population ages.

 

The report, released yesterday, highlights five major factors affecting public policy moving forward. In particular, the report acknowledges that Australia’s ageing population and rising demand for care and support services will add further pressure on our already strained health system, hospital emergency departments, and further exacerbate wait times in General Practice.

 

PSA National President Dr Fei Sim FPS said the report highlighted both the urgent and the long-term need for pharmacists in all practice areas to work to their top of scope.

 

“The Federal Government’s Intergenerational Report confirmed that our gaining population will continue to have a significant impact on the Australian economy,” she said.

 

“Combined with the rising demand for quality health care services, we must be able to ensure the long-term sustainability of our health system.

 

“Access to care is a growing issue in Australia, and the situation is exacerbated in rural and remote communities.

 

“Australians need all health professionals working to their top of scope – including pharmacists.”

 

The Federal Government also announced yesterday that ANU’s Professor Mark Cormack will lead the Unleashing the Potential of our Health Workforce Review, to be delivered in 2024.

 

“The government’s scope of practice review needs to heed the warnings of the Intergenerational report and unlock the potential of our health workforce using pharmacists,” Dr Sim said.

 

“Pharmacists are highly trained health professionals and should be supported to practise to full scope, contributing to sustainability of our health system to enable equitable access to healthcare by all Australians.

 

“There are a range of common ailments which can be safely and effectively managed by pharmacists, supported by international evidence, facilitating safe and timely care.

 

“This can only be achieved with meaningful investment and funding to empower pharmacists to deliver important health care to Australians.

 

“Pharmacists can, and should, play a significant role to improve Australian’s access to care, and contribute towards quality, safe and effective use of medicines in all parts of the healthcare system.

 

“On behalf of Australian pharmacists, I look forward to working with Professor Cormack and his team on the Unleashing the Potential of our Health Workforce Review,” Dr Sim concluded.

 

The Federal Government’s Intergenerational Report is available here.

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au